share_log

HC Wainwright & Co. Reiterates Neutral on Rain Oncologyto Neutral

Benzinga ·  Jun 2, 2023 06:34

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Rain Oncology (NASDAQ:RAIN) from Neutral to Neutral.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment